Principles and Practice of Urooncology

Gokhan Ozyigit graduated from Hacettepe University Faculty of Medicine (English) in 1996 and then obtained ECFMG Certification in the USA. In 2001 he completed his Residency at the Department of Radiation Oncology at Hacettepe University. He later became a Research Fellow at the Departments of Radiation Oncology at Washington University and The University of Texas M.D. Anderson Cancer Center. In 2004 he was appointed Assistant Professor at the Department of Radiation Oncology at Hacettepe University and in 2006 became an Associate Professor there. He is currently Chair at the Department of Radiation Oncology and Director of Advanced Cancer Technologies Research & Application Center at Hacettepe University. Dr. Ozyigit is an editorial board member of several international journals. He is also a reviewer or advisor for a number of other international journals, co-editor of seven previous books, and has authored numerous articles in peer-reviewed journals and book chapters. He received several national awards in the field of Oncology.He is a member of Board of Directors of Turkish Society for Radiation Oncology. Ugur Selek graduated from Hacettepe University, Faculty of Medicine (English), in 1997, and was certified by ECFMG in USA. He completed his Radiation Oncology Residency Program in Hacettepe University in 2001. Between 2001 and 2003, he worked at University of Texas, M.D. Anderson Cancer Center, Department of Radiation Oncology, as a Clinical Fellow focusing on IMRT and Stereotactic Radiotherapy, and was awarded with "First Annual M.D. Anderson Radiation Oncology Fellow Research Award" in 2003. After his appointment as Assistant Professor in 2004, he became an Associate Professor in the Department of Radiation Oncology at Hacettepe University in 2006. Dr Selek is currently Professor of Radiation Oncology at Koc University School of Medicine, as well as being an adjunct faculty member of U.T. M.D. Anderson Cancer Center, Department of Radiation Oncology, and Chair of American Hospital-MD Anderson Radiation Treatment Center in Istanbul since 2009. Dr. Selek is a reviewer or advisor for a number of international journals, co-editor of 2 previous books, and has authored numerous articles in peer-reviewed journals and book chapters. He is a member of ASTRO International Education Subcommittee, and member of Board of Directors of both Turkish Society for Radiation Oncology and Turkish Society of Lung Cancer.

Selection criteria based on Radiation Oncology perspective for definitive treatment approaches in urological cancers.-  Radiological imaging in urological cancers.- The role of functional imaging in urological cancers.- Surgery in renal cell cancer.-  Systemic therapies in renal cell cancer.- The role of radiotherapy in renal cell cancer.-  Screening of prostate cancer: Pros and Cons.-  Risk groupings in prostate cancer.-  Active surveillance in low risk cancer: Pros and Cons.-  Alternative focal therapies in low-risk prostate cancer: HiFU and Cryotherapy.- Robotic surgery in prostate cancer.-  Radical retropubic prostatectomy in low-high risk prostate cancer.- Guidelines for the delineation of primary tumor target volume in prostate cancer.- Guidelines for the delineation of lymphatic target volumes in prostate cancer.-  Modern radiotherapy techniques in prostate cancers.- Protontherapy for prostate cancer.-  Brachytherapy for prostate cancer.- Stereotactic body radiotherapy for prostate cancer.- The role of hormonal therapies and radiotherapy in prostate cancer.- The role of hormonal therapies after surgery.-  PSA after radiotherapy: Biochemical failure and PSA bounce.-  Adjuvant and Salvage Radiotherapy in prostate cancer.-  Reirradiation in prostate cancer.-  Systemic chemotherapies in the management of prostate cancer.- Translational research and immunotherapy in prostate cancer.-  Surgery in superficial and invasive bladder cancer.- Target volume delineation guidelines in bladder cancer.-  Bladder preservation therapies  in bladder  cancer.-  Systemic chemotherapies in bladder  cancers.-  Translational research and immunotherapy in bladder cancer.-  Radiolabelled targeted therapies in urological tumors.-   Radiation induced toxicity and related management strategies on urological malignancies.-   Quality assurance of modern radiotherapy techniques in urological malignancies.